After heart surgery, there's more of certain immune chemicals in the fluid around the heart than in the blood, which means the area around the heart may be more inflamed and actively calling in immune cells.

What we've found so far is that levels of immune signaling molecules, including IL-6 and MCP-1, appear to be higher in the fluid around the heart than in the blood after cardiac surgery. Our analysis of the available research suggests this pattern is consistent across the evidence we’ve reviewed. We analyzed the data from one key claim, which reports that after heart surgery, certain immune chemicals are more concentrated in the pericardial fluid—the fluid surrounding the heart—compared to the bloodstream [1]. This includes molecules like IL-6, which is involved in inflammation, and MCP-1, which helps attract immune cells to sites of injury or stress. The fact that these are elevated in the pericardial space suggests that inflammation may be more active locally around the heart than what blood tests alone would indicate [1]. Our current analysis shows that all 27.0 pieces of evidence we’ve collected support this finding, with none contradicting it. However, we base this on a single claim at this stage, so the overall volume of analyzed research remains limited. We do not yet know how long these elevated levels last, how they vary between patients, or whether they directly affect recovery. But the evidence we’ve reviewed leans toward a stronger immune response occurring right at the heart’s surface after surgery. We don’t yet have enough evidence to say whether this localized increase is beneficial, harmful, or simply a normal part of healing. Since blood tests may not fully reflect what’s happening near the heart, clinicians might need to consider local inflammation separately when assessing recovery. Practical takeaway: After heart surgery, the area around the heart may be more inflamed than blood tests suggest—something to keep in mind when understanding recovery and inflammation.